DRUG STUDY

DRUG STUDY

Patients Name : Mrs. CDC Hospital No. : 100022609039

Age : 54 Room No. : FSW – 4
Impression/Diagnosis: Infected Right Heel, DM II ____ Physician : Dr. Elma Baculao
CONTRAINDICATION/
HOW’S DOSAGE &
GENERIC NAME INDICATION DRUG INTERACTION SIDE EFFECTS NSG. RESPONSIBILITIES
SUPPLIED FREQUENCY

Generic Moderate to severe Contraindicated in Metabolic: Injection Humulin 1. Assess patient’s glucose
Name: diabetic ketoacidosis hypoglycemia and in hyperglycemia, (human): 70/30 level before starting therapy
Insulin or hyperglycemia, patients hypersensitive hypoglycemia. 100 45 units SQ and regularly thereafter. If
( Regular ) mild diabetic to insulin or its Respiratory: units/ml AUBF patient is under stress,
ketoacidosis, newly ingredients. dyspnea, Isophane unstable, pregnant, recently
diagnosed diabetes Drug-drug: AIDS increased cough, insulin Humulin diagnosed, or taking drugs
mellitus to control antiretrovirals, reduced suspension 70/30 30 that can interact with insulin,
Brand Name: hyperglycemia. corticosteroids, pulmonary (NPH) units SQ monitor level more
Humulin R Mechanism of dextrothyroxine, function, Insulin zinc dinner frequently.
Novolin R Action: epinephrine, thiazide respiratory tract suspension
Penfill Increases glucose diuretics may increase infection. (lente) Humulin R 2. Monitor patient’s
transport across insulin response. Beta Skin: itching, Insulin 6 units SQ glycosylated hemoglobin
muscle and fat cell blockers may conceal rash, redness, (regular) Lunch & level regularly.
membranes to reduce signs of stinging, insulin midnight.
glucose level. hypoglycemia. swelling, (lispro) 3. Monitor urine ketone level
Classification Promotes conversion Hormonal urticaria, warmth when glucose level is
: of glucose into its contraceptives may at injection site. elevated.
Antidiabetic storage form, decrease glucose Other:
glycogen (Williams tolerance, monitor anaphylaxis, 4. Be alert for adverse
& Wilkins, 2009, glucose level and hypersensitivity reaction and drug
page 689) adjust insulin dosage reactions, interactions.
carefully. lipoatrophy,
(Williams & Wilkins, lipohypertrophy, 5. Monitor injection sites for
2009, page 690) rash. local reactions.
(Williams &
Wilkins, 2009: 6. Assess patient and
page 690) family’s knowledge of drug
therapy.